Bone and Soft Tissue Tumors: Horizons in Radiomics and Artificial Intelligence

AI can improve the quality of CT, MR and PET/CT images, while simultaneously reducing imaging time, and doses of radiation and contrast. AI can improve radiologist workflow and decrease interpretation times. AI may someday be capable of accurately locating, classifying and segmenting bone and soft tissue tumors. The goal of radiomics is to use radiomic and other biomarkers to achieve "precision medicine", ie, to predict the right diagnosis and the right treatment of the right patient at the right time. Radiomic information may be helpful in guiding biopsies, classifying and grading tumors and predicting prognosis and treatment response.